Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06049355

EMBRACE: Exercising Together

EMBark on RAdiation Therapy With a Clinic-based Exercise Program: EXERCISING TOGETHER

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This phase II trial tests how well an exercise intervention, Exercising Together, works in preventing declines in physical and mental health in couples during radiation treatment for cancer. Treatments for cancer can cause side effects such as fatigue as well as strain on relationships. Exercising Together is a partnered exercise program that adds communication, collaboration and support between partners during exercise to fortify the relationship and amplify the benefits of physical training. Exercising Together program may be effective on the mental and physical health of couples during radiation treatment for cancer.

Detailed description

PRIMARY OBJECTIVE: I. To test the effectiveness and mechanisms of the adapted Exercise Together intervention on mental and physical health of couples (Aims 1 \& 2). SECONDARY OBJECTIVE: I. To gain better understanding of the implementation context and implementation outcomes (Aim 3). OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients and partners undergo Exercising Together exercise program during radiation therapy on study. Patients also undergo collection of blood samples throughout the trial. ARM II: Patients and partners receive educational materials specific to exercise. Patients also undergo collection of blood samples throughout the trial.

Conditions

Interventions

TypeNameDescription
OTHERExercise InterventionUndergo Exercise Together exercise program, a supervised group exercise program delivered online, using a live remote format
PROCEDUREBiospecimen CollectionUndergo collection of blood samples
OTHEREducational InterventionReceive educational materials

Timeline

Start date
2024-04-18
Primary completion
2028-06-30
Completion
2028-09-01
First posted
2023-09-22
Last updated
2025-05-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06049355. Inclusion in this directory is not an endorsement.